No Data
No Data
Janux Therapeutics Price Target Lowered to $41 From $62 at Scotiabank
A Quick Look at Today's Ratings for Janux Therapeutics(JANX.US), With a Forecast Between $41 to $200
Janux Therapeutics Reports Strong Financial Position and Clinical Progress
Janux Therapeutics Is Maintained at Sector Perform by Scotiabank
Janux Therapeutics Analyst Ratings
Wedbush Adjusts Price Target on Janux Therapeutics to $76 From $75, Maintains Outperform Rating
Unlock the Full List
Clement Lemons : okk
章允量 :![undefined [undefined]](https://static.moomoo.com/nnq/emoji/static/image/default/default-black.png?imageMogr2/thumbnail/36x36)
103575541 :
RetireWise : Ho ho ho... Santa Claus is coming to town
Adrianlim90 : 1
View more comments...